Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Jerry Yee, Naushaba Mohiuddin, Tudor Gradinariu, Junior Uduman & Stanley Frinak. (2020) Sodium-Based Osmotherapy in Continuous Renal Replacement Therapy: a Mathematical Approach. Kidney360 1:4, pages 281-291.
Crossref
Crossref
Ashita J. Tolwani, Michael J. ConnorJr.Jr. & Paul M. Palevsky. 2019. Chronic Kidney Disease, Dialysis, and Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation
739
753.e8
.
Alian A. Al-balas, Keith M. Wille & Ashita J. Tolwani. 2018. Core Concepts in Acute Kidney Injury. Core Concepts in Acute Kidney Injury
333
342
.
Ashita J. Tolwani & Paul M. Palevsky. 2015. Perioperative Kidney Injury. Perioperative Kidney Injury
37
51
.
Shaikh A Nurmohamed, Borefore P Jallah, Marc G Vervloet, Gul Yldirim, Pieter M ter Wee & AB Johan Groeneveld. (2013) Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study. BMC Nephrology 14:1.
Crossref
Crossref
Jorge Cerdá, Ashita Tolwani, Shamik Shah & Claudio Ronco. 2013. Modeling and Control of Dialysis Systems. Modeling and Control of Dialysis Systems
929
1009
.
Tyree H. Kiser, Robert MacLaren, Douglas N. Fish, Kathryn L. Hassell & Isaac Teitelbaum. (2012) Bivalirudin versus Unfractionated Heparin for Prevention of Hemofilter Occlusion During Continuous Renal Replacement Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30:11, pages 1117-1126.
Crossref
Crossref
Andrea Arcangeli, Bianca Rocca, Gabriella Salvatori, Mariano Ciancia, Raimondo De Cristofaro & Massimo Antonelli. (2010) Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: Effects on platelet function in the systemic circulation and across the filter. Thrombosis Research 126:1, pages 24-31.
Crossref
Crossref
Lisa D Burry, David D Tung, David Hallett, Toni Bailie, Virginia Carvalhana, David Lee, Steve Ramganesh, Robert Richardson, Sangeeta Mehta & Stephen E Lapinsky. (2009) Regional Citrate Anticoagulation for PrismaFlex Continuous Renal Replacement Therapy. Annals of Pharmacotherapy 43:9, pages 1419-1425.
Crossref
Crossref
Ashita J. Tolwani & Keith M. Wille. (2009) Anticoagulation for Continuous Renal Replacement Therapy. Seminars in Dialysis 22:2, pages 141-145.
Crossref
Crossref
Deborah M. Stein & Maureen McCunn. 2009. Critical Care Nephrology. Critical Care Nephrology
1413
1418
.
T. Cassina, R. Mauri, A. Engeler & O. Giannini. (2018) Continuous veno-venous hemofiltration with regional citrate anticoagulation: A four-year single-center experience. The International Journal of Artificial Organs 31:11, pages 937-943.
Crossref
Crossref
M. Egi, T. Naka, R. Bellomo, C. Langenberg, W. Li, N. Fealy & I. Baldwin. (2018) The Acid-Base Effect of Changing Citrate Solution for Regional Anticoagulation during Continuous Veno-Venous Hemofiltration. The International Journal of Artificial Organs 31:3, pages 228-236.
Crossref
Crossref
Boon Wee Teo, Nigel S. Kanagasundaram & Emil P. Paganini. 2008. Critical Care Medicine. Critical Care Medicine
301
326
.
M. Schmitz, G. TaskayaJ. PlumM. HennersdorfC. SuckerB. GrabenseeG. R. Hetzel. (2019) Continuous Venovenous Haemofiltration Using a Citrate Buffered Substitution Fluid. Anaesthesia and Intensive Care 35:4, pages 529-535.
Crossref
Crossref
N. Fealy, I. Baldwin, M. Johnstone, M. Egi & R. Bellomo. (2018) A Pilot Randomized Controlled Crossover Study Comparing Regional Heparinization to Regional Citrate Anticoagulation for Continuous Venovenous Hemofiltration. The International Journal of Artificial Organs 30:4, pages 301-307.
Crossref
Crossref
L. Cubattoli, M. Teruzzi, M. Cormio, L. Lampati & A. Pesenti. (2018) Citrate Anticoagulation during CVVH in High Risk Bleeding Patients. The International Journal of Artificial Organs 30:3, pages 244-252.
Crossref
Crossref
Hugh Davies & Gavin Leslie. (2007) Anticoagulation in CRRT: Agents and strategies in Australian ICUs. Australian Critical Care 20:1, pages 15-26.
Crossref
Crossref
SANDEEP MUNJAL & A AHSAN EJAZ. (2006) Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations. Nephrology 11:5, pages 405-409.
Crossref
Crossref
M.E. Herrera-Gutiérrez, G. Seller-Pérez, M. Lebrón-Gallardo, J.P. de la Cruz-cortés & J.A. González-correa. (2006) Uso de epoprostenol aislado o asociado a heparina para el mantenimiento de la permeabilidad de los circuitos de técnicas continuas de reemplazo renal. Medicina Intensiva 30:7, pages 314-321.
Crossref
Crossref
P.H.J. Van Der Voort, S.R. Postma, W.P. Kingma, E.C. Boerma & E.N. Van Roon. (2018) Safety of Citrate Based Hemofiltration in Critically Ill Patients at High Risk for Bleeding: A Comparison with Nadroparin. The International Journal of Artificial Organs 29:6, pages 559-563.
Crossref
Crossref
H. M. Oudemans-van Straaten, J. P. J. Wester, A. C. J. M. de Pont & M. R. C. Schetz. (2006) Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?. Intensive Care Medicine 32:2, pages 188-202.
Crossref
Crossref
H. M. Oudemans-van Straaten. 2006. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine
690
696
.
H. M. Oudemans-van Straaten. 2006. Intensive Care Medicine. Intensive Care Medicine
690
696
.
M. Egi, T. Naka, R. Bellomo, L. Cole, C. French, C. Trethewy, L. Wan, C.C. Langenberg, N. Fealy & I. Baldwin. (2018) A Comparison of Two Citrate Anticoagulation Regimens for Continuous Veno-Venous Hemofiltration. The International Journal of Artificial Organs 28:12, pages 1211-1218.
Crossref
Crossref
Azra Bihorac & Edward A. Ross. (2005) Continuous Venovenous Hemofiltration With Citrate-Based Replacement Fluid: Efficacy, Safety, and Impact on Nutrition. American Journal of Kidney Diseases 46:5, pages 908-918.
Crossref
Crossref
Arantxazu Isla, Alicia R Gascón, Javier Maynar, Alazne Arzuaga, Esther Corral, Alejandro Martín, María Ángeles Solinís & José Luis Pedraz Muñoz. (2005) In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes. Clinical Therapeutics 27:9, pages 1444-1451.
Crossref
Crossref
Yvonne Patricia Ympa, Yasser Sakr, Konrad Reinhart & Jean-Louis Vincent. (2005) Has mortality from acute renal failure decreased? A systematic review of the literature. The American Journal of Medicine 118:8, pages 827-832.
Crossref
Crossref
Alison Campbell. (2016) Review: Citrate Vs. Heparin for Anticoagulation in Continuous Venovenous Hemofiltration: A Prospective Randomized Study. Journal of the Intensive Care Society 5:2, pages 79-80.
Crossref
Crossref
O. Cointault, N. Kamar, P. Bories, L. Lavayssiere, O. Angles, L. Rostaing, M. Genestal & D. Durand. (2004) Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrology Dialysis Transplantation 19:1, pages 171-178.
Crossref
Crossref